Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Hanson

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Neurobiology of Disease|April 8, 2026
Restoring RCAN1 dosage mitigates sleep and EEG abnormalities in a down syndrome modelPeter Cain, Ryan Milstead, Mina Griffioen, et al.
Pilot and Feasibility Studies|February 4, 2026
ENabling VISions And Growing Expectations (ENVISAGE): Co-development and feasibility of an "integrated" version of ENVISAGE for service providers and parents of children with neurodevelopmental disabilitiesAlice Kelen Soper, Marilyn Wright, Elizabeth Chambers, et al.
Platelets|May 23, 2025
Pharmacodynamic effects of early aspirin withdrawal after percutaneous coronary intervention in patients with atrial fibrillation treated with ticagrelor or prasugrelMark A Sammut, Mohammed E F Rahman, Claire Bridge, et al.
Platelets|February 14, 2019
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndromeWilliam A E Parker, Rachel C Orme, Jessica Hanson, et al.
Journal of Medicinal Chemistry|November 1, 2016
Structure-Activity Relationships of [des-Arg<sup>7</sup>]Dynorphin A Analogues at the κ Opioid ReceptorCyf N Ramos-Colon, Yeon Sun Lee, Michael Remesic, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Neurobiology of Disease|April 8, 2026
Restoring RCAN1 dosage mitigates sleep and EEG abnormalities in a down syndrome modelPeter Cain, Ryan Milstead, Mina Griffioen, et al.
Pilot and Feasibility Studies|February 4, 2026
ENabling VISions And Growing Expectations (ENVISAGE): Co-development and feasibility of an "integrated" version of ENVISAGE for service providers and parents of children with neurodevelopmental disabilitiesAlice Kelen Soper, Marilyn Wright, Elizabeth Chambers, et al.
Platelets|May 23, 2025
Pharmacodynamic effects of early aspirin withdrawal after percutaneous coronary intervention in patients with atrial fibrillation treated with ticagrelor or prasugrelMark A Sammut, Mohammed E F Rahman, Claire Bridge, et al.
Platelets|February 14, 2019
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndromeWilliam A E Parker, Rachel C Orme, Jessica Hanson, et al.
Journal of Medicinal Chemistry|November 1, 2016
Structure-Activity Relationships of [des-Arg<sup>7</sup>]Dynorphin A Analogues at the κ Opioid ReceptorCyf N Ramos-Colon, Yeon Sun Lee, Michael Remesic, et al.
Pageof 3